A new study has demonstrated the potential of excitatory intermittent theta burst stimulation (iTBS) for reducing spasticity in patients with spinal cord injury.
Browsing: Movement disorders
Researchers have found the first evidence that autoimmunity plays a role in Parkinson’s disease, showing that T cells recognize α-synuclein peptides.
An international research team have shown that gene editing reverses Huntington’s symptoms without off-target effects in a mouse model.
Researchers discover that the drug, pyrimethamine, may reduce disease progression in patients with inherited amyotrophic lateral sclerosis (ALS).
Researchers from the University of Central Florida hope to use the CRISPR Cas9 method to screen drugs for Parkinson’s disease.
Could this new approach drive Parkinson’s disease into the age of personalized medicine?
We caught up with Regina Katzenschlager at AAN 2017, whose research into the use of apomorphine for Parkinson’s disease was highlighted at the conference as one to watch.
A patient with bilateral essential tremor has recently become the first patient in Pennsylvania (USA) to be successfully treated with a new, non-invasive, MR-guided focused ultrasound treatment.
Dr Deer discusses his career highlights, most memorable patient cases, and looks ahead at future challenges and trends in the field of neuromodulation.
Study participants receiving apomorphine also gave their treatment higher effectiveness scores than those who received the placebo.